FDA: Mylan plant probe to continue

The FDA's investigation of Mylan's quality-control practices at a Morgantown, WV plant will continue for a "few weeks," an agency spokesman told the Dominion Post. The statement comes after Mylan chief Robert Coury backpedaled on his previous claims that FDA had wrapped up the probe. Report 

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.